Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program
WeightWatchers (NASDAQ: WW) has launched a pioneering menopause program featuring Queen Latifah as its first official spokeswoman. The comprehensive program, WeightWatchers for Menopause, combines medical care, nutrition support, and community resources to support women through perimenopause to post-menopause.
The program has demonstrated significant results, with menopausal women losing nearly 4x more weight than those managing independently. Members using WeightWatchers Clinic achieved an average 18.6% body weight loss (40.1 lbs) in one year. Research from Mayo Clinic showed postmenopausal women receiving hormone therapy with GLP-1 semaglutide achieved 30% greater weight loss compared to GLP-1 alone.
WeightWatchers (NASDAQ: WW) ha lanciato un programma innovativo per la menopausa con Queen Latifah come prima testimonial ufficiale. Il programma completo, WeightWatchers for Menopause, integra assistenza medica, supporto nutrizionale e risorse di comunità per accompagnare le donne dalla perimenopausa alla post-menopausa.
I risultati ottenuti sono rilevanti: le donne in menopausa hanno perso in media rispetto a chi si gestisce autonomamente. Le utenti della WeightWatchers Clinic hanno registrato una perdita media del 18,6% del peso corporeo (40,1 lb) in un anno. Uno studio della Mayo Clinic ha inoltre evidenziato che le donne postmenopausa trattate con terapia ormonale insieme al GLP-1 semaglutide hanno ottenuto una perdita di peso del 30% superiore rispetto al GLP-1 da solo.
WeightWatchers (NASDAQ: WW) ha lanzado un programa pionero para la menopausia con Queen Latifah como su primera portavoz oficial. El programa integral, WeightWatchers for Menopause, combina atención médica, apoyo nutricional y recursos comunitarios para acompañar a las mujeres desde la perimenopausia hasta la posmenopausia.
Los resultados son notables: las mujeres en menopausia perdieron casi 4 veces más peso que quienes se gestionaron por su cuenta. Las socias que usaron la WeightWatchers Clinic lograron una pérdida media del 18,6% del peso corporal (40,1 lb) en un año. Investigaciones de la Mayo Clinic mostraron que las mujeres posmenopáusicas que recibieron terapia hormonal junto con el GLP-1 semaglutida lograron una pérdida de peso 30% mayor que con el GLP-1 solo.
WeightWatchers (NASDAQ: WW)가 Queen Latifah를 첫 공식 홍보대사로 내세운 혁신적인 폐경기 프로그램을 출시했습니다. 종합 프로그램인 WeightWatchers for Menopause는 의료 서비스, 영양 지원, 커뮤니티 자원을 결합해 폐경 전후 여성들을 돕습니다.
프로그램 성과도 두드러집니다. 폐경기 여성들은 독자적으로 관리한 여성들보다 거의 4배 가까운 체중 감소를 보였습니다. WeightWatchers Clinic 이용 회원들은 1년 동안 평균 체중의 18.6% 감량(40.1파운드)을 달성했습니다. 메이요클리닉 연구에서는 호르몬 치료와 GLP-1 세마글루타이드를 병용한 폐경 후 여성들이 GLP-1 단독 대비 30% 더 큰 체중 감소를 얻었다고 보고했습니다.
WeightWatchers (NASDAQ: WW) a lancé un programme innovant pour la ménopause avec Queen Latifah comme première porte-parole officielle. Le programme complet, WeightWatchers for Menopause, associe soins médicaux, soutien nutritionnel et ressources communautaires pour accompagner les femmes de la périménopause à la postménopause.
Les résultats sont significatifs : les femmes ménopausées ont perdu près de 4 fois plus de poids que celles qui se géraient seules. Les membres utilisant la WeightWatchers Clinic ont enregistré une perte moyenne de 18,6% du poids corporel (40,1 lb) en un an. Des recherches de la Mayo Clinic ont en outre montré que les femmes postménopausées recevant un traitement hormonal avec le GLP‑1 sémaglutide ont obtenu une perte de poids 30% supérieure à celle obtenue avec le GLP‑1 seul.
WeightWatchers (NASDAQ: WW) hat ein wegweisendes Menopause-Programm gestartet und Queen Latifah als erste offizielle Sprecherin gewonnen. Das umfassende Programm, WeightWatchers for Menopause, vereint medizinische Betreuung, Ernährungsunterstützung und Community-Ressourcen, um Frauen von der Perimenopause bis zur Postmenopause zu begleiten.
Die Ergebnisse sind beeindruckend: menopausale Frauen verloren fast viermal so viel Gewicht wie jene, die sich allein versuchten. Mitglieder der WeightWatchers Clinic erzielten im Durchschnitt einen Gewichtsverlust von 18,6% des Körpergewichts (40,1 lb) in einem Jahr. Forschungen der Mayo Clinic zeigten außerdem, dass postmenopausale Frauen, die eine Hormontherapie zusammen mit dem GLP‑1 Semaglutid erhielten, einen um 30% größeren Gewichtsverlust erzielten als mit GLP‑1 allein.
- Clinical studies show nearly 4x more weight loss compared to self-managed programs
- Members using WW Clinic achieved significant 18.6% body weight loss (40.1 lbs) in one year
- Partnership with high-profile celebrity Queen Latifah enhances brand visibility
- Expansion into specialized menopause care market addresses underserved demographic
- Integration of medical care including HRT and GLP-1 medications enhances program effectiveness
- Entering competitive medical weight loss market with established players
- Success dependent on clinical staff recruitment and training
- Program requires significant investment in medical infrastructure and training
Insights
WeightWatchers enters the $600B+ women's health market with a comprehensive menopause program combining nutrition, medical care, and celebrity endorsement.
WeightWatchers' new menopause program represents a strategic expansion into the historically underserved women's health market. This isn't merely a product extension—it's a calculated move to tap into a demographic of approximately 1 billion women worldwide experiencing perimenopause or menopause at any given time.
The program's comprehensive approach combines their core competency in weight management with medical interventions—including hormone replacement therapy and GLP-1 medications when appropriate. This integrated model addresses the multifaceted challenges of menopause beyond just weight gain, including hot flashes, sleep disturbances, and mood changes.
Their partnership with Queen Latifah is particularly astute. Rather than choosing a traditionally thin celebrity, WeightWatchers selected someone who authentically represents body diversity and has personal experience with menopause. This signals a shift in positioning from purely weight loss to comprehensive health management.
The clinical data cited is compelling: menopausal women following their program lost nearly four times more weight than those managing alone, while those using their clinical services with medication access achieved an average 18.6
By positioning themselves at the intersection of nutrition science, medical care, and community support, WeightWatchers is establishing a defensible moat against both traditional diet companies and newer digital health startups in the women's health space.
Groundbreaking Program Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking program that sets a new standard in women’s health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman
“Menopause has been a new journey for me—one that’s changed how I see and care for my body,” said Queen Latifah. “It’s shown me how important it is for women to have support that truly understands this stage of life. That’s why I’m proud to be the spokesperson for WeightWatchers’ new program. For decades, WeightWatchers has helped women live healthier, more confident lives, and now they’re once again leading the way with care designed for menopause.”
A passionate advocate for women’s health, and someone navigating the realities of menopause herself, Queen Latifah brings honesty, empathy, and relatability to a life stage that for too long has been underserved, lacking both accessible education and personalized care.
WeightWatchers for Menopause combines the best of the brand, with trusted medical care, science-backed nutrition and lifestyle support, and a compassionate community of women—to deliver accessible, personalized care for this stage of life. Developed by leading physicians, menopause specialists, and experts in fitness and nutrition, the program provides a holistic model designed to meet the distinct health needs of women from perimenopause to postmenopause. From one-on-one guidance with menopause-trained clinicians and access to evidence-based treatments, to a tailored version of the Points® Program, fitness designed for strength and stability, and workshops led by coaches who understand this stage of life, the program offers women everything they need to feel supported, informed, and empowered.
“For more than six decades, WeightWatchers has evolved with the science to meet the changing needs of our members,” said Tara Comonte, CEO of WeightWatchers. “With this first-of-its-kind menopause program we’re proud to deliver truly comprehensive care in a single plan, bringing together specialized medical expertise, science-backed nutrition, lifestyle tools and a compassionate community. This program sets a new standard for the industry and women’s health, empowering millions to feel healthier, stronger, and more confident as they navigate menopause and beyond.”
WeightWatchers has a long track record of delivering meaningful results, and this newly launched program is no exception. In studies, women of menopausal age who followed WeightWatchers’ nutritional guidance lost nearly four times more weight than those trying to manage on their own.1 For members seeking additional support, WeightWatchers Clinic has expanded to include clinicians specifically trained in menopause care. These members receive comprehensive consultations, individualized care plans, and, when appropriate, prescription options such as HRT, GLP-1s, or other evidence-based treatments, all monitored by licensed clinicians. In fact, women of menopausal age enrolled in WeightWatchers Clinic lost on average
“For many women, the changes that come with menopause can feel overwhelming. Hormone-related weight gain in particular often resists traditional methods of weight loss,” said Dr. Kim Boyd, Chief Medical Officer of WeightWatchers. “Too often women are left feeling isolated or dismissed because menopause care has been historically overlooked, hard to access, and filled with misinformation. With WeightWatchers for Menopause, we’re bringing together our six decade legacy of supporting women with a dedicated care team trained in menopause, evidence-based options like hormone therapy and GLP-1 medications—alongside a specialized curriculum and a trusted community. We are uniquely positioned to provide women in this stage of life with the guidance and tools they need to achieve real, lasting results.”
By bringing together science-backed nutrition and lifestyle change, personalized medical care, and a supportive community, WeightWatchers for Menopause offers the most comprehensive program of its kind, empowering women to feel healthier, stronger, and more supported as they navigate menopause and beyond with confidence.
For more information or to join WeightWatchers for Menopause, please visit: menopause.weightwatchers.com/us/en.
ABOUT WEIGHTWATCHERS
WeightWatchers is the global leader in science-backed weight management, offering an integrated support system that combines scientific expertise and human connection. With more than 60 years of experience, WeightWatchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions, medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has surrounded its members with the support they need to reach and sustain their goals, wherever they are on their journey. Members can access these solutions directly, or through WeightWatchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, WeightWatchers offers a proven path forward, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.
For media inquiries, please contact:
Kelsey Merkel
media@ww.com
For investor inquiries, please contact:
John Mills or Anna Kate Heller
WeightWatchers@icrinc.com
1 Based on a secondary analysis of a 6-month randomized controlled trial (n=165 women 45 years or older with complete data) that compared participants following WW to those given standard nutritional guidelines alone. Funded by WW International, Inc.
2 Hurtado, Maria D. MD, PhD1,2; Tama, Elif MD1,2; Fansa, Sima MD2; Ghusn, Wissam MD2; Anazco, Diego MD2; Acosta, Andres MD, PhD2; Faubion, Stephanie S. MD, MBA, MSCP3,4; Shufelt, Chrisandra L. MD, MS, MSCP3,4. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause 31(4):p 266-274, April 2024. | DOI: 10.1097/GME.0000000000002310. Study based on review of records for 1,023 patients between 2021 and 2023.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42cfc063-7bac-4c99-8afe-c24fce8636bb
FAQ
What is WeightWatchers' new menopause program and how does it work?
Who is the spokesperson for WeightWatchers' menopause program?
What results can women expect from WeightWatchers' menopause program?
Does WeightWatchers' menopause program offer prescription medications?
How does hormone therapy affect weight loss in WeightWatchers' program?
